179 deals. Showing the latest 60. See all in the deal sheet. Follow by RSS
Proficient Surgical, founded in 1996, serves the Northeast with surgical microscopy and operating room products; terms undisclosed.
Q Surgical, founded in 2009, serves hospitals and ASCs in Northern California and Nevada with surgical microscopes and OR products; terms undisclosed.
CSB Nutrition, a Spanish Fork, Utah-based contract manufacturer of vitamin and dietary supplements founded in 2001, joins Riverside's Western Botanicals platform.
5th Century Partners exited the Charleston, West Virginia-based medical imaging equipment service provider after more than tripling its revenue in four years.
Boston-based TA Associates is buying Germany's largest private nursing home operator from Nordic Capital, with closing expected in the first quarter of 2027.
RadNet will pay $350 million in cash and 5 million shares for ONRAD, a teleradiology and hospital radiology staffing provider owned by Housatonic Partners.
ATCO Pharma, founded in 1986, sells human and veterinary medicines in more than 10 export markets and has over 150 products.
Bon Secours affiliate agreed to take Bain Capital-backed Surgery Partners, an operator of ambulatory surgery centers and surgical hospitals, private for $5.7 billion.
Kos BioVentures makes a strategic investment in Singapore-based Golden Age Health, a commercial platform for rare and specialty medicines in Greater China and Asia-Pacific.
LGM Pharma, backed by New Harbor Capital, has acquired Sannova Analytical, a Somerset, New Jersey-based contract lab providing cGMP testing and bioanalytical services.
Star Therapeutics, a South San Francisco biotech developing antibody therapies, raised $200 million in a financing co-led by OrbiMed and Janus Henderson Investors.
TFP Fertility, backed by Amulet Capital Partners, has acquired Manchester Fertility Group, which runs a fertility clinic and laboratory in Cheadle and five brands.
Diatech Pharmacogenetics, a TA Associates-backed company, has acquired German PCR thermal cycler maker SensoQuest.
Sagility bought Chirok Health, a clinical documentation and coding services provider, for about $32.35 million to expand its provider-facing revenue cycle offerings.
ChiroHD, backed by Mainsail Partners, has acquired ChiroBilling, an outsourced chiropractic billing company founded in 2011 with 30 professionals.
EQT Private Equity will take the life-sciences tools and diagnostics provider private in a cash deal valued at €10.8 billion, with closing expected in mid-2027.
The add-on brings a provider of saliva-based diagnostic tests for oral health to the platform, with transaction terms undisclosed in the announcement.
Extens has struck a deal to sell its stake in cardiology clinical-data software maker MediReport to Philips.
Archimed has invested in Organika, a Vancouver-based nutraceutical company founded in 1990, in the first deal from the MED IV fund.
Renovus Capital has agreed to acquire Aspire, a Morton Grove, Illinois-based home health provider.
American Oncology Network, a physician-led network with more than 350 providers in 21 states, agreed to sell to Cencora for up to $2.4 billion.
Oxoid Remel, a maker of diagnostic consumables and equipment for microbiological testing, will take over the microbiology diagnostics division of fellow Astorg portfolio company Solabia.
Serving individuals with depression, anxiety, PTSD and other conditions, the Denver-based provider has more than 50 clinics across five states and over 1,300 team members.
Madrid-based trauma care, spinal and sports rehabilitation provider Tiryaq Medical Group is selling a 71% controlling stake to Buenavista.
BlackRock will acquire Welsh, Carson, Anderson & Stowe's existing equity stake for approximately $2.8 billion, becoming majority owner while CenterWell retains a minority interest and continues managing the clinics, which make up the nation's largest senior-focused primary care provider.
The Tampa Bay clinical research network operates three facilities in Tampa and Clearwater, including a dedicated Phase I unit, and works with biopharmaceutical sponsors and contract research organizations.
Bedfont Scientific acquired coVita, a US medical device company based in The Woodlands, Texas, that has served as Bedfont's US distributor for more than 16 years.
Spectrum Equity has made the first institutional investment in Pittsburgh-based Symmetric, which pushes a database of nearly 20 million healthcare items into hospital ERP systems.
The Rome-based maker of optical imaging systems for confocal and super-resolution microscopy is being sold to Evident, marking Apposite Capital's first exit from Healthcare III.
RL-007, studied in 500 subjects, adds a second clinical-stage cognition program alongside AmyriAD’s lead asset ismidenon.
CD&R and McKesson have agreed a $5.8bn take-private of Option Care Health, a home and alternate-site infusion services provider with more than 8,000 staff.
Apheon is buying a controlling stake in the dental rotary instrument maker, whose Meisinger and Jota brands sell in over 100 countries.
The company provides maintenance and servicing for more than 3,000 contrast injectors used by more than 1,000 U.S. hospital systems and imaging centers.
The Danish manufacturer operates a cGMP production site in Hvidovre and supplies pharmaceutical laboratories with controlled-substance APIs and advanced intermediates.
Its AI-powered clinical scribe automates documentation, while workflow tools support practice operations for veterinary customers across North America and Europe.
The four Nordic fish-farming technology companies provide systems for fish health, feeding, oxygen management, sea-lice control and sludge treatment to aquaculture producers.
The company provides temperature-controlled storage, handling and distribution for pharmaceutical and healthcare customers across northwest Germany.
The capital will help the Bend, Oregon-based contract development and manufacturing organization move from clinical-stage manufacturing into commercial production, with emphasis on particle engineering and spray drying.
The pending take-private offers $6.28 per share in cash plus a contingent value right tied to milestones.
Creates a unified life sciences offering that connects market research, strategy, creative, and field execution for pharmaceutical and biotech clients.
The St. Louis business coordinates spinal surgery products across manufacturers, sales representatives, hospitals and surgeons, with plans to enter additional specialties and markets.
The purchase takes GoodVets from 75 to 116 veterinary hospitals, adding practices across seven states.
Harbour Point Capital remains an investor as the Chicago provider plans wider telehealth reach.
New State-backed Expo Group adds an experiential agency serving healthcare, biotech and other regulated industries.
The specialty and generic medicines distributor serves the UK and Ireland, including NHS hospitals.
The Cambridge-based supplier adds more than one million research products and an ecommerce platform.
The healthcare media and events business reaches more than 1.5 million executives through its digital products.
The clinical scheduling software business joins Ascend’s healthcare workforce technology portfolio.
The mobile diagnostics provider coordinates a network of more than 15,000 medical providers across all 50 states.
The purchases add outpatient infusion locations in Cherry Hill, New Jersey, and Latham, New York.
The platform supports more than 135,000 healthcare practitioners across North America; closing is expected in the fourth quarter.
The health-plan analytics business receives its first institutional funding after 13 years of founder ownership.
The single-site acquisition extends Pinnacle’s Dallas-Fort Worth network and metabolic-disease research capabilities.
Allen will continue practicing at the Santa Barbara location. The acquisition was announced alongside six physician additions across Ivy's network, including reproductive urology expertise supporting its male fertility services.
The carved-out business provides contract manufacturing for life sciences, diagnostics and combination drug products.
Ambit provides commercial strategy, analytics and patient-identification services for rare and specialty biopharma markets.
The clinical trial laboratory business operates in Germany, the United States and South Africa.
The Dallas-Fort Worth practices expand Beacon’s outpatient psychiatry network in North Texas.
The completed transaction combines health economics modelling and analytics with market-access and outcomes-research consulting.
The company operates a national network covering approximately 85% of U.S. pharmacies and facilitated over 10 million clinical interventions in 2025.